World Library  
Flag as Inappropriate
Email this Article

Cell potency

Article Id: WHEBN0026982208
Reproduction Date:

Title: Cell potency  
Author: World Heritage Encyclopedia
Language: English
Subject: Neuroepithelial cell, Induced stem cells, Developmental biology, Potency, Stem cells
Collection: Cell Biology, Developmental Biology, Stem Cells
Publisher: World Heritage Encyclopedia

Cell potency

Cell potency is a cell's ability to differentiate into other cell types.[1][2] The more cell types a cell can differentiate into, the greater its potency. Potency is also described as the gene activation potential within a cell which like a continuum begins with totipotency to designate a cell with the most differentiation potential, pluripotency, multipotency, oligopotency and finally unipotency. Potency is taken from the Latin term "potens" which means "having power."

Pluripotent, embryonic stem cells originate as inner mass cells within a blastocyst. These stem cells can become any tissue in the body, excluding a placenta. Only the morula's cells are totipotent, able to become all tissues and a placenta.


  • Totipotency 1
  • Pluripotency 2
    • Induced pluripotency 2.1
  • Multipotency 3
  • Oligopotency 4
  • Unipotency 5
  • See also 6
  • References 7


Totipotency is the ability of a single Spores and Zygotes are examples of totipotent cells.[3] In the spectrum of cell potency, totipotency represents the cell with the greatest differentiation potential. Toti comes from the Latin totus which means "entirely."

It is possible for a fully differentiated cell to return to a state of totipotency.[4] This conversion to totipotency is complex, not fully understood and the subject of recent research. Research in 2011 has shown that cells may differentiate not into a fully totipotent cell, but instead into a "complex cellular variation" of totipotency.[5]

The human development model is one which can be used to describe how totipotent cells arise.[6] Human development begins when a sperm fertilizes an egg and the resulting fertilized egg creates a single totipotent cell, a zygote.[7] In the first hours after fertilization, this zygote divides into identical totipotent cells, which can later develop into any of the three germ layers of a human (endoderm, mesoderm, or ectoderm), into cells of the cytotrophoblast layer or syncytiotrophoblast layer of the placenta. After reaching a 16-cell stage, the totipotent cells of the morula differentiate into cells that will eventually become either the blastocyst's Inner cell mass or the outer trophoblasts. Approximately four days after fertilization and after several cycles of cell division, these totipotent cells begin to specialize. The inner cell mass, the source of embryonic stem cells, becomes pluripotent.

Research on Caenorhabditis elegans suggests that multiple mechanisms including RNA regulation may play a role in maintaining totipotency at different stages of development in some species.[8] Work with zebrafish and mammals suggest a further interplay between miRNA and RNA binding proteins (RBPs) in determining development differences.[9]

In September 2013, a team from the Spanish national Cancer Research Centre were able for the first time to make adult cells from mice retreat to the characteristics of embryonic stem cells thereby achieving totipotency.[10]


A: Human embryonic stem cells (cell colonies that are not yet differentiated).
B: Nerve cells

In cell biology, pluripotency (from the Latin plurimus, meaning very many, and potens, meaning having power)[11] refers to a stem cell that has the potential to differentiate into any of the three germ layers: endoderm (interior stomach lining, gastrointestinal tract, the lungs), mesoderm (muscle, bone, blood, urogenital), or ectoderm (epidermal tissues and nervous system).[12] However, cell pluripotency is a continuum, ranging from the completely pluripotent cell that can form every cell of the embryo proper, e.g., embyronic stem cells and iPSCs (see below), to the incompletely or partially pluripotent cell that can form cells of all three germ layers but that may not exhibit all the characteristics of completely pluripotent cells.

Induced pluripotency

Induced pluripotent stem cells, commonly abbreviated as iPS cells or iPSCs are a type of pluripotent stem cell artificially derived from a non-pluripotent cell, typically an adult somatic cell, by inducing a "forced" expression of certain genes and transcription factors.[13] These transcription factors play a key role in determining the state of these cells and also highlights the fact that these somatic cells do preserve the same genetic information as early embryonic cells.[14] The ability to induce cells into a pluripotent state was initially pioneered in 2006 using mouse fibroblasts and four transcription factors, Oct4, Sox2, Klf4 and c-Myc;[15] this technique called reprogramming earned Shinya Yamanaka and John Gurdon the Nobel Prize in Physiology or Medicine 2012.[16] This was then followed in 2007 by the successful induction of human iPSCs derived from human dermal fibroblasts using methods similar to those used for the induction of mouse cells.[17] These induced cells exhibit similar traits to those of embryonic stem cells (ESCs) but do not require the use of embryos. Some of the similarities between ESCs and iPSCs include pluripotency, morphology, self-renewal ability, a trait that implies that they can divide and replicate indefinitely, and gene expression.[18]

Euchromatin modifications are also common which is also consistent with the state of euchromatin found in ESCs.[18]

Due to their great similarity to ESCs, iPSCs have been of great interest to the medical and research community. iPSCs could potentially have the same therapeutic implications and applications as ESCs but without the controversial use of embryos in the process, a topic of great bioethical debate. In fact, the induced pluripotency of somatic cells into undifferentiated iPS cells was originally hailed as the end of the controversial use of embryonic stem cells. However, iPSCs were found to be potentially tumorigenic, and, despite advances,[13] were never approved for clinical stage research in the United States. Setbacks such as low replication rates and early senescence have also been encountered when making iPSCs,[19] hindering their use as ESCs replacements.

Additionally, it has been determined that the somatic expression of combined transcription factors can directly induce other defined somatic cell fates (transdifferentiation); researchers identified three neural-lineage-specific transcription factors that could directly convert mouse fibroblasts (skin cells) into fully functional neurons.[20] This result challenges the terminal nature of cellular differentiation and the integrity of lineage commitment; and implies that with the proper tools, all cells are totipotent and may form all kinds of tissue.

Some of the possible medical and therapeutic uses for iPSCs derived from patients include their use in cell and tissue transplants without the risk of rejection that is commonly encountered. iPSCs can potentially replace animal models unsuitable as well as in-vitro models used for disease research.[21]


Hematopoietic stem cells are an example of multipotency. When they differentiate into myeloid or lymphoid progenitor cells, they lose potency and become oligopotent cells with the ability to give rise to all cells of its lineage.

Multipotency describes progenitor cells which have the gene activation potential to differentiate into multiple, but limited cell types. For example, a multipotent blood stem cell is a hematopoietic cell — and this cell type can differentiate itself into several types of blood cell types like lymphocytes, monocytes, neutrophils, etc., but cannot differentiate into brain cells, bone cells or other non-blood cell types.

New research related to multipotent cells suggests that multipotent cells may be capable of conversion into unrelated cell types. In one case, fibroblasts were converted into functional neurons.[20] In another case, human umbilical cord blood stem cells were converted into human neurons.[22] Research is also focusing on converting multipotent cells into pluripotent cells [23]

Multipotent cells are found in many, but not all human cell types. Multipotent cells have been found in adipose tissue,[24] cardiac cells,[25] bone marrow, and mesenchymal stromal cells (MSCs) which are found in the third molar.[26]

MSCs may prove to be a good, reliable source for stem cells because of the ease in collection of molars at 8–10 years of age and before adult dental calcification. MSCs can differentiate into osteoblasts, chondrocytes, and adipocytes.[27]


In biology, oligopotency is the ability of progenitor cells to differentiate into a few cell types. It is a degree of potency. Examples of oligopotent stem cells are the lymphoid or myeloid stem cells.[1] A lymphoid cell specifically, can give rise to various blood cells such as B and T cells, however, not to a different blood cell type like a red blood cell.[28] Examples of progenitor cells are vascular stem cells that have the capacity to become both endothelial or smooth muscle cells.


In cell biology, a unipotent cell is the concept that one stem cell has the capacity to differentiate into only one cell type. It is currently unclear if true unipotent stem cells exist. Hepatoblasts, which differentiate into hepatocytes (which constitute most of the liver) or cholangiocytes (epithelial cells of the bile duct), are bipotent.[29] A close synonym for unipotent cell is precursor cell.

See also


  1. ^ a b Hans R. Schöler (2007). "The Potential of Stem Cells: An Inventory". In Nikolaus Knoepffler, Dagmar Schipanski, and Stefan Lorenz Sorgner. Human biotechnology as Social Challenge. Ashgate Publishing, Ltd. p. 28.  
  2. ^ "Stem Cell School: Glossary". 
  3. ^ Mitalipov S, Wolf D; Wolf (2009). "Totipotency, pluripotency and nuclear reprogramming". Advances in Biochemical Engineering & Biotechnology 114: 185–99.  
  4. ^ Western P (2009). "Foetal germ cells: striking the balance between pluripotency and differentiation". Int. J. Dev. Biol. 53 (2–3): 393–409.  
  5. ^ Sugimoto K, Gordon SP, Meyerowitz EM (April 2011). "Regeneration in plants and animals: dedifferentiation, transdifferentiation, or just differentiation?". Trends Cell Biol. 21 (4): 212–8.  
  6. ^ Seydoux G, Braun RE (December 2006). "Pathway to totipotency: lessons from germ cells". Cell 127 (5): 891–904.  
  7. ^ Asch R, Simerly C, Ord T, Ord VA, Schatten G (July 1995). "The stages at which human fertilization arrests: microtubule and chromosome configurations in inseminated oocytes which failed to complete fertilization and development in humans". Hum. Reprod. 10 (7): 1897–906.  
  8. ^ Ciosk, R.; Depalma, Michael; Priess, James R. (10 February 2006). "Translational Regulators Maintain Totipotency in the Caenorhabditis elegans Germline". Science 311 (5762): 851–853.  
  9. ^ Kedde M, Agami R (April 2008). "Interplay between microRNAs and RNA-binding proteins determines developmental processes". Cell Cycle 7 (7): 899–903.  
  10. ^ Serrano, Manuel (2013-09-11). "Study published in Nature is another step towards regenerative medicine". Retrieved 2013-12-11. 
  11. ^ "Biology Online". Retrieved 25 April 2013. 
  12. ^ Binder, edited by Marc D.; Hirokawa, Nobutaka; (eds.), Uwe Windhorst (2009). Encyclopedia of neuroscience ([Online-Ausg.] ed.). Berlin: Springer.  
  13. ^ a b Baker, Monya (2007-12-06). "Adult cells reprogrammed to pluripotency, without tumors". Nature Reports Stem Cells.  
  14. ^ Stadtfeld, M.; Hochedlinger, K. (15 October 2010). "Induced pluripotency: history, mechanisms, and applications". Genes & Development 24 (20): 2239–2263.  
  15. ^ Takahashi, Kazutoshi; Yamanaka, Shinya (August 2006). "Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors". Cell 126 (4): 663–676.  
  16. ^ "The Nobel Prize in Physiology or Medicine 2012". Nobel Media AB 2013. Web. 28 Nov 2013.
  17. ^ Takahashi, Kazutoshi; Tanabe, Koji; Ohnuki, Mari; Narita, Megumi; Ichisaka, Tomoko; Tomoda, Kiichiro; Yamanaka, Shinya (1 November 2007). "Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors". Cell 131 (5): 861–872.  
  18. ^ a b Liang, Gaoyang; Zhang, Yi (18 December 2012). "Embryonic stem cell and induced pluripotent stem cell: an epigenetic perspective". Cell Research 23 (1): 49–69.  
  19. ^ Choi, Charles. "Cell-Off: Induced Pluripotent Stem Cells Fall Short of Potential Found in Embryonic Version". Scientific American. Retrieved 25 April 2013. 
  20. ^ a b Vierbuchen T, Wernig M et al. (February 2010). "Direct conversion of fibroblasts to functional neurons by defined factors". Nature 463 (7284): 1035–41.  
  21. ^ Park, IH; Lerou, PH; Zhao, R; Huo, H; Daley, GQ (2008). "Generation of human-induced pluripotent stem cells.". Nature protocols 3 (7): 1180–6.  
  22. ^ Giorgetti A, Marchetto MC, Li M et al. (July 2012). "Cord blood-derived neuronal cells by ectopic expression of Sox2 and c-Myc". Proc. Natl. Acad. Sci. U.S.A. 109 (31): 12556–61.  
  23. ^ Guan K, Nayernia K, Maier LS et al. (April 2006). "Pluripotency of spermatogonial stem cells from adult mouse testis". Nature 440 (7088): 1199–203.  
  24. ^ Tallone T, Realini C, Böhmler A et al. (April 2011). "Adult human adipose tissue contains several types of multipotent cells". J Cardiovasc Transl Res 4 (2): 200–10.  
  25. ^ Beltrami AP, Barlucchi L, Torella D et al. (September 2003). "Adult cardiac stem cells are multipotent and support myocardial regeneration". Cell 114 (6): 763–76.  
  26. ^ Ohgushi H, Arima N, Taketani T (December 2011). "[Regenerative therapy using allogeneic mesenchymal stem cells]". Nippon Rinsho (in Japanese) 69 (12): 2121–7.  
  27. ^ Uccelli, Antonio; Moretta, Pistoia (September 2008). "Mesenchymal stem cells in health and disease". Nature Reviews 8 (9): 726–36.  
  28. ^ Ibelgaufts, Horst. "Cytokines & Cells Online Pathfinder Encyclopedia". Retrieved 25 April 2013. 
  29. ^ "hepatoblast differentiation". GONUTS. 
This article was sourced from Creative Commons Attribution-ShareAlike License; additional terms may apply. World Heritage Encyclopedia content is assembled from numerous content providers, Open Access Publishing, and in compliance with The Fair Access to Science and Technology Research Act (FASTR), Wikimedia Foundation, Inc., Public Library of Science, The Encyclopedia of Life, Open Book Publishers (OBP), PubMed, U.S. National Library of Medicine, National Center for Biotechnology Information, U.S. National Library of Medicine, National Institutes of Health (NIH), U.S. Department of Health & Human Services, and, which sources content from all federal, state, local, tribal, and territorial government publication portals (.gov, .mil, .edu). Funding for and content contributors is made possible from the U.S. Congress, E-Government Act of 2002.
Crowd sourced content that is contributed to World Heritage Encyclopedia is peer reviewed and edited by our editorial staff to ensure quality scholarly research articles.
By using this site, you agree to the Terms of Use and Privacy Policy. World Heritage Encyclopedia™ is a registered trademark of the World Public Library Association, a non-profit organization.

Copyright © World Library Foundation. All rights reserved. eBooks from Project Gutenberg are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.